801PBone metabolism biomarkers (BMB) in hormone sensitive prostate cancer (HSPC): Results from SWOG S1216, a phase III trial of androgen deprivation therapy (ADT) +/- orteronel. (23rd October 2018) - Lara, P N; Mayerson, E; Gertz, E; Tangen, C; Goldkorn, A; van Loan, M; Hussain, M; Gupta, S; Zhang, J; Twardowski, P; Quinn, D I; Vogelzang, N J; et al.